The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Current results of a phase I study of DKN-01, an anti-DKK1 antibody, in combination with paclitaxel (P) in patients (pts) with advanced DKK1+ esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).
 
David P. Ryan
Honoraria - UpToDate
Consulting or Advisory Role - Medimmune
Patents, Royalties, Other Intellectual Property - McGraw Hill Chapter Royalties
 
Janet E. Murphy
Consulting or Advisory Role - Merrimack
 
Devalingam Mahalingam
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Genentech
Research Funding - AstraZeneca; Boehringer Ingelheim; HealthCare Ventures; Lilly; Merck; Mirati Therapeutics
 
Cynthia A. Sirard
Employment - Leap Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics
Patents, Royalties, Other Intellectual Property - Leap Therapeutics
 
Steven B. Landau
Employment - Leap Therapeutics; Shape Pharmaceuticals; Tensha Therapeutics
Stock and Other Ownership Interests - Leap Therapeutics; Shape Pharmaceuticals; Tensha Therapeutics
 
Johanna C. Bendell
No Relationships to Disclose